Factors interacting with HIF-1alpha mRNA: novel therapeutic targets.
about
Hallmarks of cancer and AU-rich elementsPosttranscriptional regulation of cancer traits by HuRStable tumor vessel normalization with pO₂ increase and endothelial PTEN activation by inositol trispyrophosphate brings novel tumor treatment.RNA-binding proteins implicated in the hypoxic response.Clinicopathologic significance of HIF-1α, CXCR4, and VEGF expression in colon cancer.A pathophysiological view of the long non-coding RNA world.Photodynamic therapy-induced angiogenic signaling: consequences and solutions to improve therapeutic response.The hypoxia-inducible factor-1α activates ectopic production of fibroblast growth factor 23 in tumor-induced osteomalacia.Conditional knockout of the RNA-binding protein HuR in CD4⁺ T cells reveals a gene dosage effect on cytokine productionInteractions between nitric oxide and hypoxia-inducible factor signaling pathways in inflammatory diseaseFunctional regulation of HIF-1α under normoxia--is there more than post-translational regulation?Modulation of hypoxia-inducible factors (HIF) from an integrative pharmacological perspective.Molecular mechanisms regulating macrophage response to hypoxia.Hypoxia-inducible factor-1α as prognostic marker.CD133 Modulate HIF-1α Expression under Hypoxia in EMT Phenotype Pancreatic Cancer Stem-Like Cells.Paired proteomics, transcriptomics and miRNomics in non-small cell lung cancers: known and novel signaling cascades.Inhibitor of DNA Binding 1 Is Induced during Kidney Ischemia-Reperfusion and Is Critical for the Induction of Hypoxia-Inducible Factor-1α.Transcription regulates HIF-1α expression in CD4(+) T cells.Multilevel regulation of HIF-1 signaling by TTP.Effect of hypoxia on tissue factor pathway inhibitor expression in breast cancer.HIF1A C1772T polymorphism leads to HIF-1α mRNA overexpression in prostate cancer patients.HIF-1α expression as a protective strategy of HepG2 cells against fatty acid-induced toxicity.
P2860
Q26744134-53604E56-9231-44AF-BA6A-7806659F3089Q28248667-A8D91468-5D10-4948-9E1A-110106E139ABQ30540976-0D9C92E6-7E3D-4F37-A891-159871A53D2AQ33703426-60EE0185-673E-481B-9D88-E68966E8A208Q34189559-70B0BA23-CA20-45A4-957C-7E920E7C054BQ34957187-5DCD0020-294F-477D-B5C4-B7F4D6C12D31Q35766780-B4A5966D-F3ED-4627-996A-9757C0A59382Q37102306-CA60CD37-5BDC-4B12-AA4C-815F204A7EEEQ37649960-1383B107-4752-42BD-ABC8-AFB505B6C9EAQ37825687-3EE39A74-BD46-460C-BEE9-235AF40CBB5FQ37866715-D8C7BEB5-AED3-454A-9642-3AF83C1CC43CQ37943792-BA0D3B1E-A220-4509-9DF7-0890E686BDAFQ38008339-A8464F0F-9A57-436D-A1C1-7F0C52545535Q38093246-78AB1C25-50F1-4DD4-B53A-48F0E23161C4Q38760452-D8D1A398-7D63-4C91-9E0C-0B2E69992A46Q39428789-5847BDAE-E0C9-4758-9F7C-81849CBCEE06Q40312430-BE970E3C-5914-4A19-B520-3E5230167DEEQ41119966-AA251014-88B9-4547-8098-86511BD0339DQ42039351-E8287873-F5AF-412F-AF93-11D60B9267C9Q42485431-3D34D221-0B27-40D0-A4BA-FD376D657DAFQ43871358-E8390426-3C8A-4A80-9B51-2D3BDE436884Q51760102-F34A1AE7-382D-423E-A4FF-1B370F9FCFD8
P2860
Factors interacting with HIF-1alpha mRNA: novel therapeutic targets.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Factors interacting with HIF-1alpha mRNA: novel therapeutic targets.
@en
Factors interacting with HIF-1alpha mRNA: novel therapeutic targets.
@nl
type
label
Factors interacting with HIF-1alpha mRNA: novel therapeutic targets.
@en
Factors interacting with HIF-1alpha mRNA: novel therapeutic targets.
@nl
prefLabel
Factors interacting with HIF-1alpha mRNA: novel therapeutic targets.
@en
Factors interacting with HIF-1alpha mRNA: novel therapeutic targets.
@nl
P2860
P1476
Factors interacting with HIF-1alpha mRNA: novel therapeutic targets.
@en
P2093
Myriam Gorospe
Stefanie Galbán
P2860
P304
P356
10.2174/138161209789649376
P577
2009-01-01T00:00:00Z